Clinical Trial: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Patients With Generalized Anxiety Disorder (GAD) and Patients With Schizophrenia (SCZ)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Healthy Volunteers Generalized Anxiety Disorder (GAD) Schizophrenia (SCZ)
Study Type: INTERVENTIONAL
Official Title: A Multiple Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Subjects, Patients With Generalized Anxiety Disorder (GAD) and Patients With Sc
Brief Summary:
The purpose of this study is to assess the pharmacokinetics, safety, and tolerability following multiple ascending oral doses of ABBV-932 or placebo in healthy adult participants and patients with Generalized Anxiety Disorder (GAD) and patients with schizophrenia (SCZ).
Read more